-
1.发明申请公开(公告)号：US20070037763A1
公开(公告)日：2007-02-15
申请号：US11432155
申请日：2006-05-10
申请人： David Stein , Richard Bestwick , Patrick Iversen , Benjamin Neuman , Michael Buchmeier , Dwight Weller
发明人： David Stein , Richard Bestwick , Patrick Iversen , Benjamin Neuman , Michael Buchmeier , Dwight Weller
IPC分类号： A61K48/00 , C07H21/02 , C07F9/6512
CPC分类号： C07H21/02 , C07K14/005 , C12N15/1131 , C12N2310/11 , C12N2310/3233 , C12N2310/3513 , C12N2770/20022
摘要： A method and oligonucleotide compound for inhibiting replication of a nidovirus in virus-infected animal cells are disclosed. The compound (i) has a nuclease-resistant backbone, (ii) is capable of uptake by the infected cells, (iii) contains between 8-25 nucleotide bases, and (iv) has a sequence capable of disrupting base pairing between the transcriptional regulatory sequences in the 5′ leader region of the positive-strand viral genome and negative-strand 3′ subgenomic region. In practicing the method, infected cells are exposed to the compound in an amount effective to inhibit viral replication.
摘要翻译： 公开了用于抑制病毒感染的动物细胞中的Nidovirus复制的方法和寡核苷酸化合物。 化合物（i）具有核酸酶抗性主链，（ii）能够被感染细胞摄取，（iii）含有8-25个核苷酸碱基之间，和（iv）具有能够破坏转录之间碱基配对的序列 正链病毒基因组和负链3'亚基因组区域的5'前导区域中的调节序列。 在实施该方法中，感染的细胞以有效抑制病毒复制的量暴露于化合物。
-
2.发明申请公开(公告)号：US20050171044A1
公开(公告)日：2005-08-04
申请号：US11022358
申请日：2004-12-22
IPC分类号： A61K48/00 , C07F9/6533 , C07H21/02 , C07K14/165 , C12N15/113
CPC分类号： C07H21/02 , C07K14/005 , C12N15/1131 , C12N2310/11 , C12N2310/3233 , C12N2310/3513 , C12N2770/20022
摘要： A method and oligonucleotide compound for inhibiting replication of a nidovirus in virus-infected animal cells are disclosed. The compound (i) has a nuclease-resistant backbone, (ii) is capable of uptake by the infected cells, (iii) contains between 8-25 nucleotide bases, and (iv) has a sequence capable of disrupting base pairing between the transcriptional regulatory sequences in the 5′ leader region of the positive-strand viral genome and negative-strand 3′ subgenomic region. In practicing the method, infected cells are exposed to the compound in an amount effective to inhibit viral replication.
摘要翻译： 公开了用于抑制病毒感染的动物细胞中的Nidovirus复制的方法和寡核苷酸化合物。 化合物（i）具有核酸酶抗性主链，（ii）能够被感染细胞摄取，（iii）含有8-25个核苷酸碱基之间，和（iv）具有能够破坏转录之间碱基配对的序列 正链病毒基因组和负链3'亚基因组区域的5'前导区域中的调节序列。 在实施该方法中，感染的细胞以有效抑制病毒复制的量暴露于化合物。
-
3.发明申请公开(公告)号：US20070274957A1
公开(公告)日：2007-11-29
申请号：US11715572
申请日：2007-03-07
IPC分类号： A61K48/00
CPC分类号： C12N15/1131 , C12N2310/11 , C12N2310/3145 , C12N2310/3233 , C12N2310/3513 , C12N2760/10011
摘要： The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1.
摘要翻译： 本发明提供了反义抗病毒化合物及其在抑制竞争链球菌科家族病毒生长和用于病毒感染治疗中的用途和生产方法。 这些化合物特别可用于治疗哺乳动物中的雷亚病毒感染。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸具有12-40个亚基的序列，包括至少12个亚基，其具有与5'末端区域的19个核苷酸区域内的病毒RNA序列相关的区域互补的靶向序列 的病毒RNA，由SEQ ID NO：1鉴定的病毒互补RNA和/或mRNA。
-
4.发明申请ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ARENAVIRUS INFECTION 有权抗真菌化合物和治疗ARENAVIRUS感染的方法公开(公告)号：US20100063133A1
公开(公告)日：2010-03-11
申请号：US12547287
申请日：2009-08-25
IPC分类号： A61K31/7088 , C12N5/02 , C07H21/04
CPC分类号： C12N15/1131 , C12N2310/11 , C12N2310/3145 , C12N2310/3233 , C12N2310/3513 , C12N2760/10011
摘要： The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1.
摘要翻译： 本发明提供了反义抗病毒化合物及其在抑制竞争链球菌科家族病毒生长和用于病毒感染治疗中的用途和生产方法。 这些化合物特别可用于治疗哺乳动物中的雷亚病毒感染。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸具有12-40个亚基的序列，包括至少12个亚基，其具有与5'末端区域的19个核苷酸区域内的病毒RNA序列相关的区域互补的靶向序列 的病毒RNA，由SEQ ID NO：1鉴定的病毒互补RNA和/或mRNA。
-
5.发明授权公开(公告)号：US07582615B2
公开(公告)日：2009-09-01
申请号：US11715572
申请日：2007-03-07
CPC分类号： C12N15/1131 , C12N2310/11 , C12N2310/3145 , C12N2310/3233 , C12N2310/3513 , C12N2760/10011
摘要： The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1.
摘要翻译： 本发明提供了反义抗病毒化合物及其在抑制竞争链球菌科家族病毒生长和用于病毒感染治疗中的用途和生产方法。 这些化合物特别可用于治疗哺乳动物中的雷亚病毒感染。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸具有12-40个亚基的序列，包括至少12个亚基，其具有与5'末端区域的19个核苷酸区域内的病毒RNA序列相关的区域互补的靶向序列 的病毒RNA，由SEQ ID NO：1鉴定的病毒互补RNA和/或mRNA。
-
公开(公告)号：US20070238681A1
公开(公告)日：2007-10-11
申请号：US11608160
申请日：2006-12-07
申请人： Kenneth Dobie , Susan Freier , Michael Buchmeier , Benjamin Neuman , C. Bennett , Namir Sioufi
发明人： Kenneth Dobie , Susan Freier , Michael Buchmeier , Benjamin Neuman , C. Bennett , Namir Sioufi
IPC分类号： A61K31/712 , C07H21/02 , C07H21/04 , C12N15/87
CPC分类号： C12N15/1137 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12Y304/15001 , C12N2310/3525
摘要： Compounds, compositions and methods are provided for modulating the expression of ACE2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding ACE2. Methods of using these compounds for modulation of ACE2 expression and for diagnosis and treatment of diseases and conditions associated with expression of ACE2 are provided.
摘要翻译： 提供化合物，组合物和方法用于调节ACE2的表达。 组合物包含针对编码ACE2的核酸的寡核苷酸。 提供了使用这些化合物调节ACE2表达和诊断和治疗与ACE2表达相关的疾病和病症的方法。
-
公开(公告)号：US20070185044A1
公开(公告)日：2007-08-09
申请号：US10592435
申请日：2005-03-08
申请人： Kenneth Dobie , Susan Freier , Michael Buchmeier , Benjamin Neuman , C. Bennett , Namir Sioufi
发明人： Kenneth Dobie , Susan Freier , Michael Buchmeier , Benjamin Neuman , C. Bennett , Namir Sioufi
IPC分类号： A61K48/00
CPC分类号： C12N15/1137 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12Y304/15001 , C12N2310/3525
摘要： Compounds, compositions and methods are provided for modulating the expression of ACE2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding ACE2. Methods of using these compounds for modulation of ACE2 expression and for diagnosis and treatment of diseases and conditions associated with expression of ACE2 are provided.
摘要翻译： 提供化合物，组合物和方法用于调节ACE2的表达。 组合物包含针对编码ACE2的核酸的寡核苷酸。 提供了使用这些化合物调节ACE2表达和诊断和治疗与ACE2表达相关的疾病和病症的方法。
-
公开(公告)号：US08759307B2
公开(公告)日：2014-06-24
申请号：US12109856
申请日：2008-04-25
申请人： David A. Stein , Richard K. Bestwick , Patrick L. Iversen , Benjamin Neuman , Michael Buchmeier , Dwight D. Weller
发明人： David A. Stein , Richard K. Bestwick , Patrick L. Iversen , Benjamin Neuman , Michael Buchmeier , Dwight D. Weller
CPC分类号： C07H21/02 , C07K14/005 , C12N15/1131 , C12N2310/11 , C12N2310/3233 , C12N2310/3513 , C12N2770/20022
摘要： A method and oligonucleotide compound for inhibiting replication of a nidovirus in virus-infected animal cells are disclosed. The compound (i) has a nuclease-resistant backbone, (ii) is capable of uptake by the infected cells, (iii) contains between 8-25 nucleotide bases, and (iv) has a sequence capable of disrupting base pairing between the transcriptional regulatory sequences in the 5′ leader region of the positive-strand viral genome and negative-strand 3′ subgenomic region. In practicing the method, infected cells are exposed to the compound in an amount effective to inhibit viral replication.
摘要翻译： 公开了用于抑制病毒感染的动物细胞中的Nidovirus复制的方法和寡核苷酸化合物。 化合物（i）具有核酸酶抗性主链，（ii）能够被感染细胞摄取，（iii）含有8-25个核苷酸碱基之间，和（iv）具有能够破坏转录之间碱基配对的序列 正链病毒基因组和负链3'亚基因组区域的5'前导区域中的调节序列。 在实施该方法中，感染的细胞以有效抑制病毒复制的量暴露于化合物。
-
9.发明申请公开(公告)号：US20090012280A1
公开(公告)日：2009-01-08
申请号：US12109856
申请日：2008-04-25
申请人： David A. Stein , Richard K. Bestwick , Patrick L. Iversen , Benjamin Neuman , Michael Buchmejer , Dwight D. Weller
发明人： David A. Stein , Richard K. Bestwick , Patrick L. Iversen , Benjamin Neuman , Michael Buchmejer , Dwight D. Weller
IPC分类号： C07H21/02
CPC分类号： C07H21/02 , C07K14/005 , C12N15/1131 , C12N2310/11 , C12N2310/3233 , C12N2310/3513 , C12N2770/20022
摘要： A method and oligonucleotide compound for inhibiting replication of a nidovirus in virus-infected animal cells are disclosed. The compound (i) has a nuclease-resistant backbone, (ii) is capable of uptake by the infected cells, (iii) contains between 8-25 nucleotide bases, and (iv) has a sequence capable of disrupting base pairing between the transcriptional regulatory sequences in the 5′ leader region of the positive-strand viral genome and negative-strand 3′ subgenomic region. In practicing the method, infected cells are exposed to the compound in an amount effective to inhibit viral replication.
摘要翻译： 公开了用于抑制病毒感染的动物细胞中的Nidovirus复制的方法和寡核苷酸化合物。 化合物（i）具有核酸酶抗性主链，（ii）能够被感染细胞摄取，（iii）含有8-25个核苷酸碱基之间，和（iv）具有能够破坏转录之间碱基配对的序列 正链病毒基因组和负链3'亚基因组区域的5'前导区域中的调节序列。 在实施该方法中，感染的细胞以有效抑制病毒复制的量暴露于化合物。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.034 秒)
